Moderna Financial Statements (MRNA)

Modernasmart-lab.ru %   2020 2021 2022 2022 2023   LTM ?
Report date 26.02.2021 25.02.2022 31.12.2022 24.02.2023 23.02.2024   01.08.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 274.5 17 736 19 263 19 263 6 754   5 052
Operating Income, bln rub -763.1 13 296 9 420 9 420 -4 239   -4 635
EBITDA, bln rub ? -763.1 13 296 9 923 9 768 -3 211   -4 015
Net profit, bln rub ? -747.1 12 202 8 362 8 362 -4 714   -5 867
OCF, bln rub ? 2 027 13 620 4 981 4 981 -3 118   -3 241
CAPEX, bln rub ? 67.4 284.0 400.0 400.0 707.0   738.0
FCF, bln rub ? 1 960 13 336 4 581 4 581 -3 825   -3 979
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 1 030 1 823 4 427 4 427 6 300   6 229
Cost of production, bln rub 7.93 2 617 5 416 5 416 4 693   3 458
R&D, bln rub 1 370 1 991 3 295 3 295 4 845   4 773
Interest expenses, bln rub 9.89 18.0 0.000 29.0 38.0   28.0
Assets, bln rub 7 337 24 669 25 858 25 858 18 426   15 680
Net Assets, bln rub ? 2 561 14 145 19 123 19 123 13 854   11 712
Debt, bln rub 207.3 916.0 1 004 1 200 1 243   1 269
Cash, bln rub 5 246 17 570 9 902 9 902 8 604   8 488
Net debt, bln rub -5 039 -16 654 -8 898 -8 702 -7 361   -7 219
Ordinary share price, rub 104.5 254.0 179.6 179.6 99.5   71.1
Number of ordinary shares, mln 381.3 403.0 394.0 394.0 382.0   384.0
Market cap, bln rub 39 838 102 354 70 770 70 770 37 990   27 283
EV, bln rub ? 34 799 85 700 61 872 62 068 30 629   20 064
Book value, bln rub 2 561 14 145 19 123 19 123 13 758   11 618
EPS, rub ? -1.96 30.3 21.2 21.2 -12.3   -15.3
FCF/share, rub 5.14 33.1 11.6 11.6 -10.0   -10.4
BV/share, rub 6.72 35.1 48.5 48.5 36.0   30.3
EBITDA margin, % ? -278.0% 75.0% 51.5% 50.7% -47.5%   -79.5%
Net margin, % ? -272.2% 68.8% 43.4% 43.4% -69.8%   -116.1%
FCF yield, % ? 4.92% 13.0% 6.47% 6.47% -10.1%   -14.6%
ROE, % ? -29.2% 86.3% 43.7% 43.7% -34.0%   -50.1%
ROA, % ? -10.2% 49.5% 32.3% 32.3% -25.6%   -37.4%
P/E ? -53.3 8.39 8.46 8.46 -8.06   -4.65
P/FCF 20.3 7.68 15.4 15.4 -9.93   -6.86
P/S ? 145.1 5.77 3.67 3.67 5.62   5.40
P/BV ? 15.6 7.24 3.70 3.70 2.76   2.35
EV/EBITDA ? -45.6 6.45 6.24 6.35 -9.54   -5.00
Debt/EBITDA 6.60 -1.25 -0.90 -0.89 2.29   1.80
R&D/CAPEX, % 2 032% 701.1% 823.8% 823.8% 685.3%   646.7%
CAPEX/Revenue, % 24.6% 1.60% 2.08% 2.08% 10.5%   14.6%
Moderna shareholders